Mml Investors Services, LLC Genmab A/S Transaction History

Mml Investors Services, LLC

$27.4 Billion
Q3 2024

A detailed history of Mml Investors Services, LLC transactions in Genmab A/S stock. As of the latest transaction made, Mml Investors Services, LLC holds 73,261 shares of GMAB stock, worth $1.51 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

73,261

Previous 69,476 5.45%

Holding current value

$1.51 Million

Previous $1.75 Million 2.29%

% of portfolio

0.01%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$23.84 - $28.48 $90,234 - $107,796	3,785 Added 5.45%	73,261 $1.79 Million
Q2 2024 Aug 14, 2024	SELL	$25.13 - $30.27 $295,754 - $356,247	-11,769 Reduced 14.49%	69,476 $1.75 Million
Q1 2024 May 14, 2024	BUY	$26.43 - $32.77 $162,676 - $201,699	6,155 Added 8.2%	81,245 $2.43 Million
Q4 2023 Feb 14, 2024	BUY	$27.94 - $35.44 $690,341 - $875,651	24,708 Added 49.04%	75,090 $2.39 Million
Q3 2023 Nov 14, 2023	BUY	$35.27 - $42.24 $336,123 - $402,547	9,530 Added 23.33%	50,382 $1.78 Million
Q2 2023 Aug 14, 2023	BUY	$37.4 - $42.94 $223,876 - $257,038	5,986 Added 17.17%	40,852 $1.55 Million
Q1 2023 May 12, 2023	SELL	$34.88 - $43.22 $58,458 - $72,436	-1,676 Reduced 4.59%	34,866 $1.32 Million
Q4 2022 Feb 13, 2023	BUY	$33.8 - $47.06 $102,042 - $142,074	3,019 Added 9.01%	36,542 $1.55 Million
Q3 2022 Nov 14, 2022	BUY	$31.52 - $373.61 $253,200 - $3 Million	8,033 Added 31.51%	33,523 $1.08 Million
Q2 2022 Aug 12, 2022	BUY	$26.83 - $38.57 $1,234 - $1,774	46 Added 0.18%	25,490 $828,000
Q1 2022 May 13, 2022	SELL	$30.95 - $39.68 $33,921 - $43,489	-1,096 Reduced 4.13%	25,444 $921,000
Q4 2021 Feb 14, 2022	BUY	$35.87 - $47.12 $70,771 - $92,967	1,973 Added 8.03%	26,540 $1.05 Million
Q3 2021 Nov 15, 2021	BUY	$41.55 - $48.72 $99,221 - $116,343	2,388 Added 10.77%	24,567 $1.07 Million
Q2 2021 Aug 13, 2021	BUY	$32.88 - $44.57 $77,202 - $104,650	2,348 Added 11.84%	22,179 $906,000
Q1 2021 May 14, 2021	BUY	$30.92 - $44.4 $125,009 - $179,509	4,043 Added 25.61%	19,831 $651,000
Q4 2020 Feb 12, 2021	BUY	$33.66 - $40.76 $100,340 - $121,505	2,981 Added 23.28%	15,788 $642,000
Q3 2020 Nov 13, 2020	BUY	$33.07 - $38.68 $24,967 - $29,203	755 Added 6.26%	12,807 $469,000
Q2 2020 Aug 14, 2020	BUY	$20.05 - $33.89 $241,642 - $408,442	12,052 New	12,052 $408,000

Others Institutions Holding GMAB

# of Institutions

236

Shares Held

52.5M

Call Options Held

10.2K

Put Options Held

25.5K

View Full List

About GENMAB A/S

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $13.6B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

More about GMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mml Investors Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mml Investors Services, LLC with notifications on news.

Account

Mml Investors Services, LLC Genmab A/S Transaction History